IPP REVENUE HITS

Saturday, March 16, 2013

Standard Operating Procedure – Drug Distributor: Reporting of Adverse Drug Reactions/Events

(Header as exampled by FDA)


Objective:
  • To minimize morbidity and mortality in patients in all areas of health care today.
  • To identify rare adverse drug reactions not detected during clinical trials.
  • To monitor for increases in already known reactions.
  • To identify risk factors or pre-existing conditions that promotes reactions.

Scope:
  • Future adverse drug reactions
  • Customer reports
  • Adverse drug events

Responsibility:
  • Pharmacist

Procedure:
  • Encourage reporting of serious or unexpected adverse drug reactions to the FDA.
  • Monitor for adverse events involving drugs and devices in continual, collaborative fashion.
  • Report adverse drug reactions to the FDA.

Quality of Records:
  • Reporting and recording of drugs that are sold and may have new adverse drug reaction.
  • List all drugs which has adverse drug reaction.

Forms:
  • Logbook and official receipt

End of Document

Mobile footer